Per Soelberg Sørensen
Professor emeritus, Professor, emeritus
- 2011
- Published
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Giovannoni, G., Cook, S., Rammohan, K., Rieckmann, P., Sørensen, Per Soelberg, Vermersch, P., Hamlett, A., Viglietta, V., Greenberg, S. & CLARITY study group, C. S. G., 2011, In: Lancet Neurology. 10, 4, p. 329-37 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study
Oturai, A., Søndergaard, H. B., Sørensen, Per Soelberg & International Multiple Sclerosis Genetics Consortium, I. M. S. G. C., 2011, In: P L o S One. 6, 4, p. e18813Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?
Koch-Henriksen, N. & Sørensen, Per Soelberg, 2011, In: Journal of the Neurological Sciences. 311, 1-2, p. 58-63 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2010
- Published
Demyelination versus remyelination in progressive multiple sclerosis
Bramow, S., Frischer, J. M., Lassmann, H., Koch-Henriksen, N., Lucchinetti, C. F., Sørensen, Per Soelberg & Laursen, H., 1 Oct 2010, In: Brain. 133, 10, p. 2983-98 16 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
EFNS guidelines on diagnosis and management of neuromyelitis optica
Sellner, J., Boggild, M., Clanet, M., Hintzen, R. Q., Illes, Z., Montalban, X., Du Pasquier, R. A., Polman, C. H., Sørensen, Per Soelberg & Hemmer, B., 1 Aug 2010, In: European Journal of Neurology. 17, 8, p. 1019-32 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients
Enevold, C., Oturai, A. B., Sørensen, Per Soelberg, Ryder, L. P., Koch-Henriksen, N. & Bendtzen, K., 1 Aug 2010, In: Multiple Sclerosis. 16, 8, p. 942-9 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci
Sørensen, Per Soelberg & International Multiple Sclerosis Genetics Conssortium (IMSGC), I. M. S. G. C. (., 1 Jul 2010, In: Genes and Immunity. 11, 5, p. 397-405 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
Ravnborg, M., Sørensen, Per Soelberg, Andersson, M., Celius, E. G., Jongen, P. J., Elovaara, I., Bartholomé, E., Constantinescu, C. S., Beer, K., Garde, E. & Sperling, B., 1 Jul 2010, In: Lancet Neurology. 9, 7, p. 672-80 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
Polman, C. H., Bertolotto, A., Deisenhammer, F., Giovannoni, G., Hartung, H., Hemmer, B., Killestein, J., McFarland, H. F., Oger, J., Pachner, A. R., Petkau, J., Reder, A. T., Reingold, S. C., Schellekens, H. & Sørensen, Per Soelberg, 1 Jul 2010, In: Lancet Neurology. 9, 7, p. 740-50 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis
Radue, E., Stuart, W. H., Calabresi, P. A., Confavreux, C., Galetta, S. L., Rudick, R. A., Lublin, F. D., Weinstock-Guttman, B., Wynn, D. R., Fisher, E., Papadopoulou, A., Lynn, F., Panzara, M. A., Sandrock, A. W., SENTINEL Investigators, S. I., Sørensen, Per Soelberg & Blinkenberg, M. B., 15 May 2010, In: Journal of the Neurological Sciences. 292, 1-2, p. 28-35 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 11025
Most downloads
-
245
downloads
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
187
downloads
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
162
downloads
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
Research output: Contribution to journal › Journal article › Research › peer-review
Published